DA32 Life Science Tech Acquisition Corp. (DALS): Price and Financial Metrics
DALS Price/Volume Stats
| Current price | $10.32 | 52-week high | $11.22 |
| Prev. close | $10.30 | 52-week low | $9.68 |
| Day low | $10.30 | Volume | 2,200 |
| Day high | $10.32 | Avg. volume | 88,802 |
| 50-day MA | $10.25 | Dividend yield | N/A |
| 200-day MA | $10.03 | Market Cap | 264.71M |
DALS Stock Price Chart Interactive Chart >
DA32 Life Science Tech Acquisition Corp. (DALS) Company Bio
DA32 Life Science Tech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Latest DALS News From Around the Web
Below are the latest news stories about DA32 LIFE SCIENCE TECH ACQUISITION CORP that investors may wish to consider to help them evaluate DALS as an investment opportunity.
Deerfield Management Company, L.P. (Series C) Boosts Holding in DA32 Life Science Tech ...Firm real-time pick highlight |
DA32 Life Science Tech Acquisition Corp. Announces Redemption of SharesNEW YORK, July 21, 2023--DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock (the "Public Shares"), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. |
DALS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 1.67% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...